Faeth Therapeutics remote work and careers
Unlocking the power of metabolism to treat cancer.
About Faeth Therapeutics
Faeth Therapeutics is a clinical-stage biotechnology company pioneering multi-node inhibition of the PAM (PI3K/AKT/mTOR) pathway, one of the most frequently altered oncogenic pathways in cancer. Our lead program, PIKTOR, is an investigational all-oral combination designed to achieve deeper pathway suppression with greater tolerability by targeting multiple nodes simultaneously. We are advancing a pipeline of therapies with the goal of improving outcomes for patients with some of the most challenging cancers.
Mission and direction
Faeth Therapeutics is a clinical-stage biotechnology company developing novel oncology therapies that target the PAM (PI3K/AKT/mTOR) pathway through multi-node inhibition. The company focuses on advancing oral combination treatments designed to achieve deeper pathway suppression, improve tolerability, and ultimately deliver better outcomes for patients with difficult-to-treat cancers.
Company values
- Care deeply
- Create boldly
- Never stop learning
- Patient-focused
- Scientific rigor
- Collaboration